MedPath

Vitamin C

Generic Name
Vitamin C
Brand Names
Ascor, Citranatal B-calm Kit, Concept Ob, Ferralet 90, Hematogen, Infuvite, Infuvite Pediatric, Moviprep, Mvc-fluoride, Mvi Pediatric, Natafort, Plenvu, Pregvit, Vitafol-one
Drug Type
Small Molecule
Chemical Formula
C6H8O6
CAS Number
50-81-7
Unique Ingredient Identifier
PQ6CK8PD0R
Background

A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.

Indication

Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.

Associated Conditions
Common Cold, Deficiency, Vitamin A, Deficiency, Vitamin D, Fever, Flu caused by Influenza, Folate deficiency, Iron Deficiency (ID), Iron Deficiency Anemia (IDA), Oral bacterial infection, Scurvy, Vitamin C Deficiency, Vitamin Deficiency
Associated Therapies
Nutritional supplementation, Vitamin supplementation

Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized Study

Phase 3
Terminated
Conditions
Metabolic Diseases
Oxidative Stress
First Posted Date
2006-10-12
Last Posted Date
2006-10-12
Lead Sponsor
University of Turin, Italy
Target Recruit Count
80
Registration Number
NCT00387114
Locations
🇮🇹

Department of Internal Medicine, University of Turin, Turin, Italy

NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization

Phase 4
Completed
Conditions
Kidney Failure
First Posted Date
2006-07-27
Last Posted Date
2006-11-27
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
250
Registration Number
NCT00356954
Locations
🇰🇷

Seoul National University Hospital , Cardiovascular Center, Seoul, Korea, Republic of

The Effect of High Dose Vitamin C in Burn Patients

Not Applicable
Withdrawn
Conditions
Burns
First Posted Date
2006-07-10
Last Posted Date
2011-12-20
Lead Sponsor
United States Army Institute of Surgical Research
Registration Number
NCT00350077
Locations
🇺🇸

United States Army Institute of Surgical Research, Fort Sam Houston, Texas, United States

L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes

Phase 2
Suspended
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndrome
First Posted Date
2006-05-24
Last Posted Date
2006-10-26
Lead Sponsor
Samsung Medical Center
Target Recruit Count
25
Registration Number
NCT00329498
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Safety of Antioxidants During GYN Cancer Care

Phase 2
Completed
Conditions
Uterine Cancer
Ovarian Cancer
Cervical Cancer
Interventions
First Posted Date
2006-01-31
Last Posted Date
2016-02-10
Lead Sponsor
Jeanne Drisko, MD, CNS, FACN
Target Recruit Count
25
Registration Number
NCT00284427

Ascorbic Acid Treatment in CMT1A Trial (AATIC)

Phase 2
Completed
Conditions
Charcot-Marie-Tooth Disease
Hereditary Motor and Sensory Neuropathies
Interventions
Drug: Placebo
Drug: ascorbic acid
First Posted Date
2006-01-04
Last Posted Date
2008-07-04
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Target Recruit Count
13
Registration Number
NCT00271635
Locations
🇳🇱

Department of Neurology Academic Medical Center University of Amsterdam, Amsterdam, P.O.Box 22660, Netherlands

Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia

Phase 2
Terminated
Conditions
Acute Myelogenous Leukemia
Interventions
First Posted Date
2005-09-16
Last Posted Date
2014-07-25
Lead Sponsor
University of Southern California
Target Recruit Count
11
Registration Number
NCT00184054
Locations
🇺🇸

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States

Treatment of Acute Schizophrenia With Vitamin Therapy

Phase 4
Completed
Conditions
Acute Schizophrenia
First Posted Date
2005-09-01
Last Posted Date
2009-11-25
Lead Sponsor
Beersheva Mental Health Center
Target Recruit Count
55
Registration Number
NCT00140166
Locations
🇮🇱

Beersheva Mental Health Center, Beersheva, Israel

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Phase 2
Withdrawn
Conditions
Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma
Refractory Plasma Cell Neoplasm
First Posted Date
2005-06-03
Last Posted Date
2013-07-10
Lead Sponsor
The Cleveland Clinic
Registration Number
NCT00112879
Locations
🇺🇸

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2
Withdrawn
Conditions
Stage II Multiple Myeloma
Stage III Multiple Myeloma
Refractory Plasma Cell Neoplasm
First Posted Date
2004-06-11
Last Posted Date
2013-07-10
Lead Sponsor
Oncotherapeutics
Registration Number
NCT00085345
Locations
🇺🇸

Comprehensive Blood and Cancer Center, Bakersfield, California, United States

🇺🇸

Hematology-Oncology Medical Group of Fresno, Incorporated, Fresno, California, United States

🇺🇸

Utah Cancer Specialists - Administrative Office, Salt Lake City, Utah, United States

and more 15 locations
© Copyright 2025. All Rights Reserved by MedPath